Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Merck & Co., Inc. (MRK) had Normalized Pre-Tax Income of $-1.79B for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
$14.63B |
|
$-1.23B |
|
$3.91B |
|
$10.72B |
|
$16.34B |
|
$-1.71B |
|
$-334.00M |
|
$-2.05B |
|
Normalized Pre-Tax Income |
$-1.79B |
$-1.23B |
|
$-1.23B |
|
$-1.23B |
|
$-508.17M |
|
$-1.71B |
|
$-748.00M |
|
2.54B |
|
2.55B |
|
$-0.49 |
|
$-0.48 |
|
Balance Sheet Financials | |
$32.17B |
|
$23.05B |
|
$74.51B |
|
$106.67B |
|
$25.69B |
|
$33.68B |
|
$43.35B |
|
$69.04B |
|
$37.63B |
|
$-1.57B |
|
$37.63B |
|
2.53B |
|
Cash Flow Statement Financials | |
$13.01B |
|
$-14.08B |
|
$-4.81B |
|
$12.77B |
|
$6.91B |
|
$-5.86B |
|
$645.00M |
|
$-7.45B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.47 |
|
0.93 |
|
73.26% |
|
-11.70% |
|
-11.70% |
|
-- |
|
-13.98% |
|
-8.38% |
|
$9.14B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.62 |
|
1.41 |
|
63.66 |
|
-3.26% |
|
77.94% |
|
-1.15% |
|
-1.72% |
|
$14.87 |
|
$3.59 |
|
$5.11 |